Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 170

Similar articles for PubMed (Select 18371377)

1.

Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, Tripodo C, Russo A, Gulotta G, Medema JP, Stassi G.

Cell Stem Cell. 2007 Oct 11;1(4):389-402. doi: 10.1016/j.stem.2007.08.001.

2.

Chemotherapy and cancer stem cells.

Rich JN, Bao S.

Cell Stem Cell. 2007 Oct 11;1(4):353-5. doi: 10.1016/j.stem.2007.09.011.

3.

Identification and expansion of human colon-cancer-initiating cells.

Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R.

Nature. 2007 Jan 4;445(7123):111-5. Epub 2006 Nov 19.

PMID:
17122771
4.

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.

O'Brien CA, Pollett A, Gallinger S, Dick JE.

Nature. 2007 Jan 4;445(7123):106-10. Epub 2006 Nov 19.

PMID:
17122772
5.

miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.

Ma S, Tang KH, Chan YP, Lee TK, Kwan PS, Castilho A, Ng I, Man K, Wong N, To KF, Zheng BJ, Lai PB, Lo CM, Chan KW, Guan XY.

Cell Stem Cell. 2010 Dec 3;7(6):694-707. doi: 10.1016/j.stem.2010.11.010.

6.

CD133+CD44+ population efficiently enriches colon cancer initiating cells.

Haraguchi N, Ohkuma M, Sakashita H, Matsuzaki S, Tanaka F, Mimori K, Kamohara Y, Inoue H, Mori M.

Ann Surg Oncol. 2008 Oct;15(10):2927-33. doi: 10.1245/s10434-008-0074-0. Epub 2008 Jul 29.

PMID:
18663533
7.

Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.

Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS Jr, Crawford H, Dufour A, Ju J, Wang Y, Leyfman Y, Botchkina GI.

Cancer Genomics Proteomics. 2009 Jan-Feb;6(1):19-29.

8.

Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.

Wang J, Wang X, Jiang S, Lin P, Zhang J, Wu Y, Xiong Z, Ren JJ, Yang H.

Cell Mol Neurobiol. 2008 Nov;28(7):991-1003. doi: 10.1007/s10571-008-9273-2. Epub 2008 Mar 19.

PMID:
18350379
9.

Identification and expansion of the tumorigenic lung cancer stem cell population.

Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R.

Cell Death Differ. 2008 Mar;15(3):504-14. Epub 2007 Nov 30.

10.

STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH⁺/CD133⁺ stem cell-like human colon cancer cells.

Lin L, Fuchs J, Li C, Olson V, Bekaii-Saab T, Lin J.

Biochem Biophys Res Commun. 2011 Dec 16;416(3-4):246-51. doi: 10.1016/j.bbrc.2011.10.112. Epub 2011 Oct 31.

PMID:
22074823
11.

A tumor hypoxic niche protects human colon cancer stem cells from chemotherapy.

Mao Q, Zhang Y, Fu X, Xue J, Guo W, Meng M, Zhou Z, Mo X, Lu Y.

J Cancer Res Clin Oncol. 2013 Feb;139(2):211-22. doi: 10.1007/s00432-012-1310-3. Epub 2012 Sep 30.

PMID:
23052691
12.

Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.

Annabi B, Lachambre MP, Plouffe K, Sartelet H, Béliveau R.

Mol Carcinog. 2009 Oct;48(10):910-9. doi: 10.1002/mc.20541.

PMID:
19326372
13.

Identification of cancer stem-like cells in the C6 glioma cell line and the limitation of current identification methods.

Shen G, Shen F, Shi Z, Liu W, Hu W, Zheng X, Wen L, Yang X.

In Vitro Cell Dev Biol Anim. 2008 Jul-Aug;44(7):280-9. doi: 10.1007/s11626-008-9115-z. Epub 2008 Jul 2.

PMID:
18594936
14.

Expression of CD133 correlates with differentiation of human colon cancer cells.

Feng HL, Liu YQ, Yang LJ, Bian XC, Yang ZL, Gu B, Zhang H, Wang CJ, Su XL, Zhao XM.

Cancer Biol Ther. 2010 Feb;9(3):216-23. Epub 2010 Feb 16.

15.

Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.

Rutella S, Bonanno G, Procoli A, Mariotti A, Corallo M, Prisco MG, Eramo A, Napoletano C, Gallo D, Perillo A, Nuti M, Pierelli L, Testa U, Scambia G, Ferrandina G.

Clin Cancer Res. 2009 Jul 1;15(13):4299-311. doi: 10.1158/1078-0432.CCR-08-1883. Epub 2009 Jun 9.

16.

Isolation and characterization of cancer stem like cells in human glioblastoma cell lines.

Qiang L, Yang Y, Ma YJ, Chen FH, Zhang LB, Liu W, Qi Q, Lu N, Tao L, Wang XT, You QD, Guo QL.

Cancer Lett. 2009 Jun 28;279(1):13-21. doi: 10.1016/j.canlet.2009.01.016. Epub 2009 Feb 15.

PMID:
19232461
17.

Copper-64-diacetyl-bis (N4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma.

Yoshii Y, Furukawa T, Kiyono Y, Watanabe R, Waki A, Mori T, Yoshii H, Oh M, Asai T, Okazawa H, Welch MJ, Fujibayashi Y.

Nucl Med Biol. 2010 May;37(4):395-404. doi: 10.1016/j.nucmedbio.2009.12.011. Epub 2010 Feb 10.

PMID:
20447549
18.

Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.

Michishita M, Akiyoshi R, Yoshimura H, Katsumoto T, Ichikawa H, Ohkusu-Tsukada K, Nakagawa T, Sasaki N, Takahashi K.

Res Vet Sci. 2011 Oct;91(2):254-60. doi: 10.1016/j.rvsc.2010.11.016. Epub 2010 Dec 28.

PMID:
21190702
19.

IL-4-mediated drug resistance in colon cancer stem cells.

Todaro M, Perez Alea M, Scopelliti A, Medema JP, Stassi G.

Cell Cycle. 2008 Feb 1;7(3):309-13. Epub 2007 Nov 30. Review.

20.

Characteristics of CD133(+) human colon cancer SW620 cells.

Kawamoto H, Yuasa T, Kubota Y, Seita M, Sasamoto H, Shahid JM, Hayashi T, Nakahara H, Hassan R, Iwamuro M, Kondo E, Nakaji S, Tanaka N, Kobayashi N.

Cell Transplant. 2010;19(6):857-64. doi: 10.3727/096368910X508988. Epub 2010 Jun 29.

PMID:
20587144
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk